Inventor · disambiguated record
Terence Seward Baker
Also filed as: BAKER TERENCE S · BAKER TERENCE SEWARD
38 granted patents·7 pending applications·594 citations·filing 1983–2024
97Inventor score
Top patents by PatentIndex Score
45 records- 0195US8926977B2Antibodies to the E1 extracellular loop of ion channelsMILLER KAREN MARGRETE·Filed 2010·Granted Jan 6, 2015·100 cites·9 claims
- 0294US5500350ABinding assay deviceCELLTECH LTD·Filed 1994·Granted Mar 19, 1996·191 cites·4 claims
- 0391US8580265B2Antibody molecules which bind IL-17A and IL-17FADAMS RALPH·Filed 2012·Granted Nov 12, 2013·16 cites·10 claims
- 0491US8507654B2Altered antibodiesBAKER TERENCE S·Filed 2007·Granted Aug 13, 2013·14 cites·9 claims
- 0589US10287343B2Tau-binding antibodiesUCB BIOPHARMA SPRL·Filed 2016·Granted May 14, 2019·5 cites·32 claims
- 0688US11261242B2Anti-alpha-synuclein antibodiesUCB Biopharma SRL·Filed 2018·Granted Mar 1, 2022·3 cites·21 claims
- 0788US9266953B2Methods of treating pain using function modifying NAv1.7 antibodiesUCB BIOPHARMA SPRL·Filed 2014·Granted Feb 23, 2016·8 cites·8 claims
- 0888US8734798B2Function modifying NAv 1.7 antibodiesFINNEY HELENE MARGARET·Filed 2010·Granted May 27, 2014·16 cites·23 claims
- 0988US2024376191A1Antibody molecules which bind il-17a and il-17fUCB Biopharma SRL·Filed 2024·Application pending·0 cites
- 1087US10889640B2Tau-binding antibodiesUCB BIOPHARMA SPRL·Filed 2019·Granted Jan 12, 2021·2 cites·10 claims
- 1187US5604110ABinding assay deviceCELLTECH THERAPEUTICS LTD·Filed 1995·Granted Feb 18, 1997·107 cites·6 claims
- 1286US10344081B2Tau-binding antibodiesUCB BIOPHARMA SPRL·Filed 2016·Granted Jul 9, 2019·3 cites·38 claims
- 1386US8986954B2DNA encoding function modifying Nav1.7 antibodiesUCB PHARMA SA·Filed 2014·Granted Mar 24, 2015·6 cites·6 claims
- 1485US9234037B2Method to generate antibodies to ion channelsBAKER TERENCE S·Filed 2012·Granted Jan 12, 2016·4 cites·21 claims
- 1584US7531676B2LipidsCELLTECH R&D LTD·Filed 2005·Granted May 12, 2009·7 cites·19 claims
- 1683US10906966B2Tau-binding antibodiesUCB Biopharma SRL·Filed 2019·Granted Feb 2, 2021·1 cites·19 claims
- 1782US9988446B2Methods of treatment using antibodies which bind IL-17A and IL-17FUCB BIOPHARMA SPRL·Filed 2015·Granted Jun 5, 2018·2 cites·26 claims
- 1880US9067995B2Method to generate antibodies to ion channelsBAKER TERENCE S·Filed 2010·Granted Jun 30, 2015·3 cites·19 claims
- 1980US2023331833A1Tau-binding antibodiesUCB Biopharma SRL·Filed 2023·Application pending·0 cites
- 2078US11919950B2Expression vector encoding antibody molecule which binds IL-17A and IL-17FUCB Biopharma SRL·Filed 2020·Granted Mar 5, 2024·0 cites·8 claims
- 2178US4656143AHeterogeneous binding assayBAKER TERENCE S·Filed 1984·Granted Apr 7, 1987·39 cites·4 claims
- 2278US2023416350A1Tau-binding antibodiesUCB Biopharma SRL·Filed 2023·Application pending·0 cites
- 2376US2024352083A1Antibodies comprising a polypeptide inserted in framework 3 regionUCB Biopharma SRL·Filed 2024·Application pending·0 cites
- 2475US9034600B2DNA encoding antibody molecules which bind IL-17A and IL-17FUCB PHARMA SA·Filed 2013·Granted May 19, 2015·1 cites·9 claims
- 2574US11292831B2Anti-alpha synuclein antibodiesUCB Biopharma SRL·Filed 2018·Granted Apr 5, 2022·1 cites·21 claims
- 2673US11746145B2Tau-binding antibodiesUCB Biopharma SRL·Filed 2020·Granted Sep 5, 2023·0 cites·18 claims
- 2772US6506881B1Anti-HMFG antibodies and processes for their productionCELLTECH R&D LTD·Filed 1995·Granted Jan 14, 2003·23 cites·3 claims
- 2871US11732034B2Tau-binding antibodiesUCB Biopharma SRL·Filed 2020·Granted Aug 22, 2023·0 cites·15 claims
- 2971US8053564B2Cross-linked antibodiesUCB PHARMA SA·Filed 2005·Granted Nov 8, 2011·1 cites·4 claims
- 3067US11999772B2Antibodies comprising a polypeptide inserted in framework 3 regionUCB Biopharma SRL·Filed 2019·Granted Jun 4, 2024·0 cites·32 claims
- 3167US11942188B2Obtaining an improved therapeutic ligandUCB Biopharma SRL·Filed 2020·Granted Mar 26, 2024·0 cites·19 claims
- 3265US2018346561A1Antibody molecules which bind il-17a and il-17fUCB BIOPHARMA SPRL·Filed 2018·Application pending·0 cites
- 3364US9738710B2Method of treating a patient for pain by administering an anti-ion channel antibodyUCB BIOPHARMA SPRL·Filed 2014·Granted Aug 22, 2017·0 cites·10 claims
- 3463US12410244B2Anti-alpha-synuclein antibodiesUCB Biopharma SRL·Filed 2022·Granted Sep 9, 2025·0 cites·15 claims
- 3561US9956274B2Method to generate antibodies to ion channelsUCB BIOPHARMA SPRL·Filed 2016·Granted May 1, 2018·0 cites·19 claims
- 3659US6583301B1LipidsCELLTECH R&D LTD·Filed 1999·Granted Jun 24, 2003·17 cites·43 claims
- 3759US2004024220A1LipidsCELLTECH R&D LTD·Filed 2003·Application pending·0 cites
- 3858US10112996B2Function modifying NAv1.7 antibodiesUCB BIOPHARMA SPRL·Filed 2016·Granted Oct 30, 2018·0 cites·12 claims
- 3957US2016125124A1Obtaining an Improved Therapeutic LigandUCB BIOPHARMA SPRL·Filed 2014·Application pending·0 cites
- 4053US4587212AImmunoassayBOOTS CELLTECH DIAGNOSTICS·Filed 1983·Granted May 6, 1986·7 cites·12 claims
- 4145US10842884B2Endosomolytic agents for gene therapyUCB Biopharma SRL·Filed 2017·Granted Nov 24, 2020·0 cites·21 claims
- 4244US12327613B2De novo antibody designUCB Biopharma SRL·Filed 2016·Granted Jun 10, 2025·0 cites·22 claims
- 4339US4716109AImmunoassayBOOTS CELLTECH DIAGNOSTICS·Filed 1984·Granted Dec 29, 1987·7 cites·18 claims
- 4439US4508830AAssayBAKER TERENCE S·Filed 1983·Granted Apr 2, 1985·10 cites·14 claims
- 4534US7718157B1Targeted lipid particlesBAKER TERENCE SEWARD·Filed 2000·Granted May 18, 2010·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Terence Seward Baker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →